Eszopiclone

규격

138729-47-2CAS 번호

620-471-1EC 번호

[(7S)-6-(5-chloro-2-pyridinyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylateIUPAC 명칭

C17H17ClN6O3화학식

388.8 g/mol분자량

Eszopiclone; 138729-47-2; Lunesta; (S)-Zopiclone; Estorra; Esopiclone; (+)-Zopiclone; Eszopiclon; Eszopiclone civ; SEP-190; eszopiclona; DTXSID8046086; UZX80K71OE; (+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate; [(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate; CHEBI:53760; GSK-1755165; 1-Piperazinecarboxylic acid, 4-methyl-, (5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl ester; DTXCID6026086; (5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate; (5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate; eszopiclonum; Zopiclone s-; ((7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo(3,4-b)pyrazin-7-yl) 4-methylpiperazine-1-carboxylate; (+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl-4-methylpiperazine-1-carboxylate; (+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate; 1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl ester; 1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester; RefChem:56355; N05CF04; (+)-(5S)-6(chloropyridine-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)-pyrazin-5-yl-4-methyl-piperazine-1-carboxylate; (S)-6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl-4-methyl-1-piperazinecarboxylate; Zopiclone s-form; SEP-225441; NCGC00159515-02; Eszopiclone [USAN:INN]; C17H17ClN6O3; Lunivia; (S)-Eszopiclone; Estorra (TN); Lunesta (TN); CAS-138729-47-2; HSDB 7472; SR-05000001914; DEA No. 2784; UNII-UZX80K71OE; Eszopiclone [USAN]; (5S)-6-(5-CHLOROPYRID-2-YL)-5-(4-METHYLPIPERAZIN-1-YL)CARBONYLOXY-7-OXO-6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRAZINE; KS-1055; SEP-0227018; SEP-0227108; ESZOPICLONE [INN]; ESZOPICLONE [JAN]; Eszopiclone (S-Zopiclone); ESZOPICLONE [HSDB]; ESZOPICLONE [VANDF]; CHEMBL1522; ESZOPICLONE [MART.]; SCHEMBL28657; ESZOPICLONE [WHO-DD]; [(7S)-6-(5-chloro-2-pyridyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate; MLS001165744; orb146149; Eszopiclone (JAN/USP/INN); SPECTRUM1505188; ZOPICLONE S-FORM [MI]; GTPL7429; ESZOPICLONE [ORANGE BOOK]; ESZOPICLONE CIV [USP-RS]; GBBSUAFBMRNDJC-INIZCTEOSA-N; HMS2864O09; HMS3259B17; HMS3264F04; ESZOPICLONE [USP MONOGRAPH]; Tox21_111733; BDBM50247998; MFCD03700720; AKOS015895596; Tox21_111733_1; AC-5546; AC-5547; CCG-213172; DB00402; NC00663; NCGC00159515-03; FE156792; SMR000550478; NS00116255; D02624; AB00828423_06; Q413184; SR-05000001914-1; SR-05000001914-2; BRD-K29220403-001-10-8; (6-(5-Chloro-2-pyridyl)-6,7-dihydro-7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl) -4-methyl-1-piperazine carboxylate; (S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate; 1140433-81-3; ゾピクロン동의어